Review By K.M. Global Financial Services Ltd on December 8, 2012
Issue Period: December 7th-11th
Issue Price (Rs): 700-750
Issue Size (Rs Cr): 504-540
Minimum Order Size: 20 Shares
Mcap (Rs Cr): 2,000-2,141
Listing: NSE, BSE
Promoters: Professionally Run, No Identifiable Promoter
Grey Market Estimate Premium: Rs 180
BRLM: Kotak Investment Banking, ICICI Securities Ltd, BofA Merrill Lynch, Edelweiss, IDBI Capital, SBI Capital Markets
Offer For Sale
IDBI Bank: 24,54,400 Shares
Canara Bank: 21,71,200 Shares
SBI: 9,14,500 Shares
IL&FS: 8,55,500 Shares
Federal Bank: 5,84,100 Shares
Tata Investment: 1,00,000 Shares
Anchor Investors
Centaura: 186,620 Shares (14.0 Rs Crores)
Birla Sun Life: 138,667 Shares (10.4 Rs Crores)
Goldman India Fund: 100,000 Shares (7.5 Rs Crores)
Eastspring Invest: 100,000 Shares (7.5 Rs Crores)
Wellington Mgmt: 100,000 Shares (7.5 Rs Crores)
DB Intl Asia: 100,000 Shares (7.5 Rs Crores)
CARE Ratings is the second largest rating company in India in terms of rating turnover. They offer a wide range of rating and grading services across a diverse range of instruments and industries. CARE also provides general and customized industry research reports. Since incorporation in April 1993, CARE has completed 19,058 rating assignments and has rating relationships with 4,644 clients as of September 30, 2012.
Strengths & Expansion Plans
Risks
Management:
CARE Ratings is headed by Mr. D.R. Dogra who holds the positions of MD and CEO. He has over 34 years of experience in the financial sector and in credit administration. He is associated with the company since inception and was appointed to the board in 2008. Prior to joining CARE he was associated with Dena Bank as a credit manager.
Rajesh Mokashi is the Deputy MD of the company. He joined CARE when the operations commenced and has more than 27 years of experience in finance, commerce and credit risk sectors. Rajesh has been associated with OTIS Elevators, DSP financial consultants and Kotak Mahindra Finance in the past.
As per CARE's HR policy, key managerial personnel are required to retire from employment by the age of 60.
We recommend that investors subscribe to the IPO of CARE Ratings as the issue has been priced at a valuation well below its peers such as ICRA and CRISIL. CARE has delivered consistent earnings growth while maintaining a return on equity of over 30%.
Retail investors should apply for the minimum order size as the issue is expected to be heavily oversubscribed which will lead to a low allotment ratio to most investors.
Review By K.M. Global Financial Services Ltd on December 8, 2012
The initial public offer (IPO) of Credit Analysis & Research Ltd. offers an early investment opportunity in Credit Analysis & Research Ltd.. A stock market investor can buy CARE IPO shares by applying in IPO before Credit Analysis & Research Ltd. shares get listed at the stock exchanges. An investor could invest in CARE IPO for short term listing gain or a long term.
Read the CARE IPO recommendations by the leading analyst and leading stock brokers.
CARE IPO offers an opportunity to buy IPO shares before they get listed at the stock exchanges. Read the CARE IPO Notes, Analysis and Recommendations by leading stock brokerage firms and experts mentioned in the above answer to "How is CARE IPO?"
Our recommendation for CARE IPO is to subscribe.
As per the analysis by our lead analyst Mr. Dilip Davda, we suggest you to subscribe to the CARE IPO.
The CARE IPO allotment status will be available on or around [.]. The allotted shares will be credited in demat account by [.]. Visit CARE IPO allotment status to check.
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O